
MOTION FOR A RESOLUTION on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole
Adopted
Reference: B9-0103/2019
Date: 10.10.2019
PfEIdentity and Democracy (ID)
23 Members
Group Voting Result
- 17For
- 1Against
- 0Abstention
- 5Did not vote
Majority of the group: For · 1 deviates
Majority = position with the most votes in the group; "Did not vote" does not count. In case of a tie there is no majority and no deviators.
Group Members


Philippe Olivier

Jordan Bardella

Roman Haider

André Rougé

Tom Vandendriessche

Mathilde Androuët

Virginie Joron

Thierry Mariani

Isabella Tovaglieri

Paolo Borchia

Harald Vilimsky

Catherine Griset

Jean-paul Garraud

Nicolas Bay

France Jamet

Ivan David

Markus Buchheit

Georg Mayer

Gerolf Annemans

Christine Anderson

Jaak Madison
